![Raymond C. Egan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Raymond C. Egan
Keine laufenden Positionen mehr
Karriereverlauf von Raymond C. Egan
Ehemalige bekannte Positionen von Raymond C. Egan
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
MIRATI THERAPEUTICS | Vorsitzender | 01.01.2000 | 25.08.2010 |
Bristol Laboratories, Inc. | Präsident | - | - |
Mead Johnson International Ltd. | Präsident | - | - |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - | - |
eMedguides.com, Inc.
![]() eMedguides.com, Inc. Internet Software/ServicesTechnology Services eMedguides.com, Inc. provides an online and in-print internet directory for medical professionals. The company was founded by Daniel Goldenson and Raymond C. Egan and is headquartered in Princeton, NJ. | Vorsitzender | 05.01.2010 | - |
Gründer | - | - |
Ausbildung von Raymond C. Egan
Syracuse University | Masters Business Admin |
Trinity College (Connecticut) | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Kanada | 3 |
Operativ
Chairman | 2 |
President | 2 |
Founder | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 3 |
Technology Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
Private Unternehmen | 4 |
---|---|
eMedguides.com, Inc.
![]() eMedguides.com, Inc. Internet Software/ServicesTechnology Services eMedguides.com, Inc. provides an online and in-print internet directory for medical professionals. The company was founded by Daniel Goldenson and Raymond C. Egan and is headquartered in Princeton, NJ. | Technology Services |
Mirati Therapeutics, Inc.
![]() Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |
Mead Johnson International Ltd. | |
Bristol Laboratories, Inc. |
- Börse
- Insiders
- Raymond C. Egan
- Erfahrung